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In humans and mice, chronic UVB irradiation 
(wavelengths; 290–320 nm) induces cutaneous 
inflammation, photoaging, and gene mutations 
that can lead to the development of malignan-
cies at affected sites (Kligman, 1996; Melnikova 
and  Ananthaswamy,  2005).  Although  factors 
that  promote  UV-induced  innate  responses 
have been investigated intensively (Melnikova 
and Ananthaswamy, 2005), less is known about 
regulatory mechanisms that can limit UVB- 
induced inflammation.
Although mast cells were once thought to 
function primarily as proinflammatory effector 
cells that can contribute to either allergic reac-
tions (Galli et al., 2005) or inflammation caused 
by innate responses to exogenous environmen-
tal agents such as UV irradiation (Metz et al., 
2006), recent evidence indicates that, in certain 
settings, mast cells can also limit inflammation 
and tissue injury, including that induced by 
UVB irradiation (Grimbaldeston et al., 2007; 
Galli et al., 2008). Mast cells are well positioned 
to participate in cutaneous immune responses, 
as skin mast cells are located predominately in 
the dermis near blood and lymphatic vessels 
and nerves. Although the majority of UVB rays 
do not penetrate to the dermis (Noonan and 
De Fabo, 1992), the UVB-dependent activa-
tion  of  dermal  mast  cells  is  thought  to  be 
achieved indirectly, e.g., via nerve growth fac-
tor  derived  from  the  epidermis  (Hart  et  al., 
2002; Townley et al., 2002) or by sensory C fi-
bers (which innervate the epidermis and ex-
tend into the dermis) that have been activated 
by cis-urocanic acid (Hart et al., 1999, 2002; 
Khalil et al., 2001). Such indirect mechanisms 
of mast cell activation contribute to the UVB-
induced systemic immunosuppression of acquired 
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Mast cell production of interleukin-10 (IL-10) can limit the skin pathology induced by 
chronic low-dose ultraviolet (UV)-B irradiation. Although the mechanism that promotes 
mast cell IL-10 production in this setting is unknown, exposure of the skin to UVB irradia-
tion induces increased production of the immune modifying agent 1,25-dihydroxyvitamin 
D3 (1,25[OH]2D3). We now show that 1,25(OH)2D3 can up-regulate IL-10 mRNA expres-
sion and induce IL-10 secretion in mouse mast cells in vitro. To investigate the roles of 
1,25(OH)2D3 and mast cell vitamin D receptor (VDR) expression in chronically UVB-
irradiated skin in vivo, we engrafted the skin of genetically mast cell–deficient WBB6F1-
KitW/W-v mice with bone marrow–derived cultured mast cells derived from C57BL/6 
wild-type or VDR/ mice. Optimal mast cell–dependent suppression of the inflammation, 
local production of proinflammatory cytokines, epidermal hyperplasia, and epidermal  
ulceration associated with chronic UVB irradiation of the skin in KitW/W-v mice required 
expression of VDR by the adoptively transferred mast cells. Our findings suggest that 
1,25(OH)2D3/VDR-dependent induction of IL-10 production by cutaneous mast cells can 
contribute to the mast cell’s ability to suppress inflammation and skin pathology at sites of 
chronic UVB irradiation.
© 2010 Biggs et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it  is  available  under  a  Creative  Commons  License  (Attribution–Noncommer-
cial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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IL-10 in response to 1,25(OH)2D3. 1,25(OH)2D3 stimu-
lated the de novo synthesis and release of IL-10 by mast cells 
without  inducing  concomitant  degranulation  (Fig.  S1  C). 
Thus, although both WT and VDR/ BMCMCs degranu-
lated (Fig. S2 A) and released IL-6 and TNF (Fig. S2, B and C) 
upon stimulation with IgE and specific antigen, BMCMCs 
did not degranulate in response to 1,25(OH)2D3 (Fig. S1 C).
Absence of mast cell VDR exacerbates UVB-induced  
skin pathology
The finding that 1,25(OH)2D3 induced BMCMCs to pro-
duce IL-10 in vitro raised the possibility that biologically active 
vitamin D3 is the link between chronic low-dose UVB ir-
radiation and mast cell IL-10 production (Grimbaldeston et al., 
2007). To test this hypothesis, we exposed the ears of WT 
WBB6F1-Kit+/+ (Kit+/+) mice, mast cell–deficient WBB6F1-
KitW/W-v (KitW/W-v) mice, and KitW/W-v mice which had been 
engrafted with BMCMCs from WT (i.e., B6-VDR+/+) mice 
(WT BMCMC→KitW/W-v mice) or from B6-VDR-deficient 
mice (VDR/ BMCMC→KitW/W-v mice) to one minimal 
erythema dose of UVB every 2 d for 15 exposures (total cu-
mulative dose, 30 kJ/m2 UVB). This UVB irradiation regi-
men resulted in scabbing of the ears, indicative of full-thickness 
epidermal necrosis and ulceration (Grimbaldeston et al., 2007), 
in 7/9 KitW/W-v mice and 6/12 VDR/ BMCMC→KitW/W-v 
mice, but in none of 11 WT mice or 9 WT BMCMC→
KitW/W-v mice (Table I). Moreover, compared with WT or 
WT BMCMC→KitW/W-v mice, mast cell–deficient KitW/W-v 
mice and VDR/ BMCMC→KitW/W-v mice exhibited sig-
nificantly greater increases in ear thickness after UVB irradia-
tion (Fig. 2 A), with such differences being evident on day 8, 
just before the fifth UVB exposure, and continuing through-
out the remainder of the UVB irradiation regimen.
After completion of the UVB irradiation regimen, mast 
cell–deficient KitW/W-v mice and VDR/ BMCMC→KitW/W-v 
mice exhibited more substantial skin pathology by histology 
immune responses in mice subjected to a single acute dose 
(12  kJ/m2)  of  UVB  irradiation  (Hart  et  al.,  1998,  2002). 
However, it is not clear how mast cells are activated when 
the skin is exposed to multiple cycles of UVB irradiation.
We investigated whether vitamin D3 (or cholecalciferol), 
which has important effects in immunity (van Etten and 
Mathieu, 2005; Moro et al., 2008), might influence mast 
cell function during chronic low-dose UVB irradiation. 
Vitamin D3 is synthesized in the epidermis upon UVB- 
induced photochemical conversion of 7-dehydrocholesterol 
to previtamin D3, which then undergoes spontaneous thermal 
isomerization to vitamin D3 (Lehmann, 2005; Moro et al., 
2008). Vitamin D3 is converted into its biologically active 
metabolite, 1,25-dihydroxyvitamin D3 (1,25[OH]2D3) via 
the 25-hydroxylation of vitamin D3 by the cytochrome P450 
proteins CYP2DII, CYP2D25, CYP3A4, or CYP2R1, fol-
lowed by the hydroxylation of 25(OH)D3 to 1,25(OH)2D3 
by CYP27B1 (Lehmann, 2005; Bouillon et al., 2008; Moro 
et al., 2008).
Recently, we reported evidence that mast cell production 
of the antiinflammatory cytokine IL-10 can limit the inflam-
mation and tissue damage associated with chronic low-dose 
UVB irradiation of mouse skin (Grimbaldeston et al., 2007). 
UVB irradiation can increase production of vitamin D3, and 
mouse mast cells can express receptors for vitamin D3 (i.e., 
vitamin D receptor [VDR]; Baroni et al., 2007). We therefore 
investigated whether 1,25(OH)2D3 can activate mast cells to 
produce IL-10 and to what extent effects mediated via mast cell 
VDRs contribute to the mast cell’s ability to curtail the skin 
pathology associated with chronic low-dose UVB irradiation.
RESULTS AND DISCUSSION
Vitamin D3 activates mast cells to produce IL-10  
without inducing degranulation
1,25(OH)2D3 functions primarily by binding to its nuclear 
receptor,  VDR,  which  recruits  its  preferred  dimerization 
partner, the retinoid X receptor, to form a heterodimer that 
acts as a ligand-dependent transcription factor by binding to 
vitamin D response elements in the promoter regions of 
target genes (Kato et al., 2007; Bouillon et al., 2008). Many 
immune cells express VDRs, and 1,25(OH)2D3 can elicit 
inhibitory effects in macrophages and dendritic cells (for 
review see van Etten and Mathieu, 2005), direct naive CD4+ T 
cells toward a Th2–IL-10–producing phenotype (Boonstra et al., 
2001), and enhance the suppressive activity of CD4+CD25+ 
T cells (Gorman et al., 2007).
We found that C57BL/6J (B6) mouse BM-derived cul-
tured mast cells (BMCMCs; i.e., B6-VDR+/+ BMCMCs), 
like BALB/c BMCMCs (Baroni et al., 2007), expressed VDRs 
(Fig. 1 A) and, unlike B6-VDR/ BMCMCs, exhibited in-
creased levels of IL-10 mRNA 6 h after 1,25(OH)2D3 stim-
ulation (Fig. S1 A). Exposure to 1,25(OH)2D3 for 24 h   
in vitro induced B6-VDR+/+ BMCMCs to secrete IL-10 
(Fig. 1 B), whereas for B6-VDR/ BMCMCs levels of IL-10 
were below the limit of detection (Fig. S1 B). Thus, mouse 
mast cells require functional VDRs to synthesize and release 
Figure 1.  1,25(OH)2D3-induced IL-10 production by BMCMCs. 
(A) FACS analysis of WT (B6) BMCMCs and VDR/ BMCMCs for VDR ex-
pression. (B) IL-10 in supernatants of 5-wk-old (B6J) BMCMCs cultured 
for 24 h with 0.1–1,000 nM 1,25(OH)2D3. Data (n = 5 per group) are  
of mean values obtained in five different experiments (all measure-
ments for each experiment were performed in duplicate). *, P < 0.05 or  
**, P < 0.01 for the indicated comparisons. See Fig. S1 B for data using 
VDR/ BMCMCs.JEM VOL. 207, March 15, 2010  457
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or VDR/ BMCMC→KitW/W-v mice, as this enables assess-
ment of mast cell contributions in the absence of confound-
ing effects of skin pigmentation.
Epidermal thickening in response to UVB exposure also 
can enhance the resistance of the skin to some of the harmful 
effects of UV irradiation (Kligman, 1996). Moreover, func-
tional VDRs may be required to mount an effective defense 
against excessive UV-induced damage (Ellison et al., 2008). 
Although all three groups of UVB-treated white KitW/W-v 
mice (including the two BMCMC-engrafted groups) exhib-
ited significantly more epidermal thickening than the UVB-
treated WT mice, the presence of either WT or VDR/ 
mast cells resulted in significantly reduced UVB-induced epi-
dermal thickening than was observed in mast cell–deficient 
KitW/W-v mice, with WT mast cells exhibiting a larger protec-
tive effect than VDR/ mast cells (Fig. S3).
Mast cell VDRs are required for optimal curtailment  
of UVB-induced inflammation
The UVB-induced ear swelling responses (Fig. 2 A) and   
pathology (Fig. 3 K) of VDR/ BMCMC→KitW/W-v mice 
resembled those observed in IL-10/ BMCMC→KitW/W-v 
mice.  We  confirmed  our  finding  (Grimbaldeston  et  al., 
2007) that the ear skin of UVB-treated mast cell–deficient 
KitW/W-v mice, compared with the identically treated skin of 
WT BMCMC→KitW/W-v mice or WT mice, contained 
  significantly higher numbers of every population of granulo-
cytes, macrophages, or CD4+ T cells analyzed (Fig. 4). Adult 
WBB6F1-KitW/W-v mice have reduced numbers of neutro-
phils in the BM, blood, and spleen (Chervenick and Boggs, 
1969; Nigrovic et al., 2008; Piliponsky et al., 2010). Despite 
the possibility that this neutrophil deficiency might influ-
ence inflammatory responses in KitW/W-v mice, all three 
groups of KitW/W-v mice tested (i.e., those with or without 
than did either of the other groups, including extensive der-
mal leukocyte infiltration, edema, and/or expansion of the 
dermis (Fig. 3, B, E, H, and K). The differences between the 
two groups of BMCMC-engrafted mice were not caused by 
disparities in the extent of mast cell engraftment, as similar 
numbers of ear pinna mast cells were present in the two 
groups (Fig. 2 B and Fig. 3, I and L).
As expected, the highly pigmented (black) WT mice had 
the smallest responses to UVB irradiation (Fig. 3, B and C). 
The capacity of UVB exposure to induce increased melanin 
pigmentation can further enhance the ability of the skin of 
WT mice to resist deleterious effects of UVB (Yamazaki   
et al., 2004; Melnikova and Ananthaswamy, 2005). By con-
trast, the white KitW/W-v mice essentially lack skin melano-
cytes, as well as mast cells. Therefore, it is essential to compare 
the UVB-induced responses in the ears of mast cell–deficient 
KitW/W-v mice with those in WT BMCMC→KitW/W-v mice 
Table I.  Mast cell VDR expression is required for optimal 
limitation of full thickness epidermal necrosis associated with 
chronic low-dose UVB irradiation
UVB-treated mice Mice with full thickness epidermal 
necrosis/total treated
WBB6F1-Kit+/+ 0 / 11
WBB6F1-KitW/W-v 7 / 9*
WT BMCMCs→KitW/W-v 0 / 9
VDR–/– BMCMCs→KitW/W-v 6 / 12*
The data depict the numbers of mice whose ears exhibited scabbing (indicative of 
full thickness epidermal necrosis) and, in some cases, ulcers. Ears were assessed by 
clinical observation and/or histology during or at the end of the period of UVB 
exposure. *, P < 0.05 versus WT (Kit+/+) mice or WT BMCMC-engrafted KitW/W-v (WT 
BMCMCs→KitW/W-v); data summarize the results of the three independent 
experiments we performed (n = 3–4 mice/group per experiment), each of which 
gave similar results.
Figure 2.  Mast cell VDR expression helps to limit tissue swelling associated with chronic low-dose UVB irradiation. (A) Ear swelling after 15 
exposures to 2 kJ/m2 of UVB (each arrowhead indicates a single exposure) in WT WBB6F1-Kit+/+ mice (black diamond, Kit+/+; n = 11), mast cell–deficient 
WBB6F1-KitW/W-v mice (open diamond, KitW/W-v; n = 9), and WBB6F1-KitW/W-v mice engrafted in the ear pinnae with WT C57BL/6-VDR+/+ BMCMCs (light 
gray diamond, WT BMCMC→KitW/W-v, n = 9) or VDR/ BMCMCs (dark gray circle, VDR/ BMCMC→KitW/W-v; n = 12). ***, P < 0.0001 for the indicated 
comparisons between groups of UVB-irradiated mice. Data (n = 9–12 per group) are from the three independent experiments performed (each with three 
to four mice per group), each of which gave similar results. Ear swelling measurements in ears not irradiated with UVB (“no UVB”) are highly overlapping 
for the four groups of mice; for each group, responses in UVB-irradiated ears were significantly different from those in the non-UVB–irradiated ears at  
P < 0.0001. (B) Numbers of dermal mast cells in ear pinnae after 15 exposures to 2 kJ/m2 of UVB. *, P < 0.05; **, P < 0.01; ***, P < 0.001; or ****, P < 0.0001, 
for the indicated comparisons. Data (3–12 mice per group) are from the three experiments performed, each of which gave similar results; each experi-
ment analyzed one ear from a mouse not treated with UVB (– UVB) and single ears from three to four UVB-treated (+ UVB) mice.458 Mast cell VDRs reduce UVB-induced skin injury | Biggs et al.
Notably, the highest levels of CD4+CD25+FoxP3+ T cells 
(a subset of regulatory T cells that has been implicated in a mast 
cell–dependent pathway required for normal expression of   
peripheral tolerance to skin allografts (Lu et al., 2006)) were 
observed in the groups of mice that developed the most severe 
inflammation: WBB6F1-KitW/W-v mice and, to a lesser extent, 
VDR/ BMCMC→KitW/W-v mice (Fig. 4 D). Much lower 
levels of CD4+CD25+FoxP3+ T cells, which were statistically 
indistinguishable from those observed in the UVB-irradiated 
skin of WT mice, occurred in the UVB-irradiated skin of WT 
BMCMC→KitW/W-v mice (Fig. 4 D). This finding does not 
exclude the possibility that mast cells can enhance resistance to 
adverse effects of chronic UVB irradiation in part by effects on 
adoptively-transferred mast cells) had significantly higher 
numbers of granulocytes in the UVB-treated ears than the 
identically-treated WT mice, with mast cell–deficient KitW/W-v 
mice exhibiting the highest level of infiltrating granulo-
cytes (Fig. 4 A and B). Also, numbers of Gr-1hi granulocytes, 
as well as CD4+ and CD4+CD25+CD62L– T cells, in UVB-
exposed  ear  skin  of  VDR/  BMCMC→KitW/W-v  mice 
were significantly lower than in mast cell–deficient KitW/W-v 
mice but higher than in WT BMCMC→KitW/W-v mice   
(Fig. 4, B and D). Thus, although adoptively transferred 
VDR/ mast cells limited numbers of leukocytes in the 
UVB-treated skin of WBB6F1-KitW/W-v mice, they were 
not as effective as WT mast cells.
Figure 3.  Mast cells and mast cell VDR expression are required to limit pathology induced by chronic low-dose UVB irradiation of ear skin. 
Cross sections of ears obtained from WBB6F1-Kit+/+ (WT) mice (A–C), WBB6F1-KitW/W-v (KitW/W-v) mice (D–F), WT BMCMC→KitW/W-v mice (G–I), or VDR/ 
BMCMC→KitW/W-v mice (J–L) at 24 h after the final exposure to 2 kJ/m2 UVB (15 exposures, 2 d apart; B, C, E, F, H, I, K, and L); sections stained with H&E 
(A, B, D, E, G, H, J, and K), or Toluidine blue (C, F, I, and L). Mice that did not receive UVB irradiation were also killed for analysis of skin histology at the end 
of the experiment (A, D, G, and J). C*, cartilage. Double-headed arrows indicate thickness of dermis (D) or epidermis (Ep). Red arrowheads indicate mast 
cells (C, F, I, and L). Bars: 100 µm (inset in A; for A–L); 1,000 µm (A; for insets in A, B, D, E, G, H, J, and L); 10 µm (C and I insets). Results are representative 
of those obtained in the three different experiments performed, each with three to four mice analyzed per group.JEM VOL. 207, March 15, 2010  459
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et al., 2002; Townley et al., 2002), neuropeptides derived from 
sensory C fibers (Hart et al., 2002), and locally produced endo-
thelin-1 (Metz et al., 2006). However, it remains to be deter-
mined whether these mechanisms of mast cell activation occur 
during our model of chronic UVB irradiation.
Loss of mast cell VDRs alters the cytokine profile  
in UVB-irradiated skin
We assessed cutaneous levels of IL-10, IL-4, IL-6, and   
TNF 24 h after either the 4th or 15th exposure to UVB 
  irradiation (Fig. 5, A–D). We confirmed our prior finding 
(Grimbaldeston et al., 2007) that after 15 UVB exposures   
skin levels of IL-10 were higher in WT Kit+/+ mice and in 
WT BMCMC→KitW/W-v mice than in mast cell–deficient   
KitW/W-v mice, and we also found that skin IL-10 levels in 
VDR/ BMCMC→KitW/W-v mice were not significantly 
different from those in mast cell–deficient KitW/W-v mice 
(Fig. 5 A). The highest levels of IL-10 were observed in WT 
BMCMC→KitW/W-v mice after four UVB exposures, coincid-
ing with the start of lower ear swelling responses in these mice 
CD4+CD25+FoxP3+ T cells, but our results do show that large 
numbers of such cells can appear in UVB-irradiated skin that is 
essentially devoid of mast cells. These results are consistent 
with the possibility that, in settings in which there is little or no 
mast cell–dependent suppression of inflammation, there can be 
a compensatory increase in the deployment of other mecha-
nisms that can reduce tissue damage, including those mediated 
by regulatory T cells.
Our findings strongly support the conclusion that optimal 
mast cell–dependent suppression of the inflammation and tis-
sue pathology associated with chronic UVB irradiation of the 
skin of WBB6F1-KitW/W-v mice requires that mast cells express 
VDR. However, other mechanisms of mast cell activation 
probably also contribute to their anti-inflammatory effects in 
this  setting,  as  some  features  of  the  pathology  induced  by 
chronic UVB irradiation were reduced in WBB6F1-KitW/W-v 
mice that had been engrafted with VDR/ mast cells. Based 
on prior work with various models of UVB irradiation of 
mouse skin, such mechanisms of dermal mast cell activation 
may include keratinocyte-derived nerve growth factor (Hart   
Figure 4.  Mast cell VDR expression helps to limit leukocyte numbers in ear skin exposed to chronic low-dose UVB irradiation. Flow cytomet-
ric analysis of granulocytes and macrophages (A and B) and CD4+ and CD4+CD25+ T cells (C and D) 24 h after the last of 15 exposures to 2 kJ/m2 UVB 
irradiation (+ UVB) or at control sites not treated with UVB irradiation (– UVB) in ear skin of WBB6F1-Kit+/+ (WT) mice, mast cell–deficient WBB6F1-KitW/W-v 
(KitW/W-v) mice, WT BMCMC→KitW/W-v mice, and VDR/ BMCMC→KitW/W-v mice. Percentage values in A and C refer to percentage of total viable cells 
present in the depicted section of the plot. (A) Representative FACS plots of granulocytes and macrophages in ears derived from individual mice. (B) Gran-
ulocytes (gated population R1, Gr-1hi; R2, Gr-1+) and macrophages (macs; R3 [“activated macrophages”], F4/80+ Gr-1hi; R4, F4/80+) recovered per ear.  
(C) Representative FACS plots of T cell populations in ears derived from individual mice, where live populations of CD3+ T cells were first gated and then 
CD4+CD25+CD62L T cells were selected, and where 4% paraformaldehyde-fixed CD4+ T cells were gated, and then CD25+ FoxP3+ T cells were selected. 
Percentages of gated T cell populations indicated are the percentage of the total cell population in that ear. (D) CD4+ T cell populations recovered per ear 
based on flow cytometric analysis of fixed cells (for CD4+CD25+FoxP3+ T cells) or live cells (the other three groups). (B and D) Data (n = 6–12 per group) 
are of mean values from 3 different experiments, each of which gave similar results, in which individual ears of three to four mice per group were ana-
lyzed in each experiment. *, P < 0.05; **, P < 0.01; ***, P < 0.001 for the indicated comparisons.460 Mast cell VDRs reduce UVB-induced skin injury | Biggs et al.
UVB-irradiated skin of KitW/W-v mice and VDR/  
BMCMC→KitW/W-v  mice  also  exhibited  higher  levels  of 
TNF than those in UVB-treated skin of WT mice or WT 
BMCMC→KitW/W-v mice (Fig. 5 D). TNF may have a pro-
inflammatory role (Galli et al., 2008) in this setting, but TNF 
has pleiotropic activities and has been implicated as a poten-
tial immunosuppressive cytokine in some models of UVB ir-
radiation  (Alard  et  al.,  1999).  Although  the  factors  that 
regulate the levels and function of cytokines at sites of UVB 
irradiation are complex, our results indicate that, in our model 
of chronic UVB irradiation, dermal mast cells have effects 
that can increase levels of IL-10 and decrease levels of IL-4, 
IL-6, and TNF, at least in the skin of KitW/W-v mice. More-
over, to perform such roles most effectively (particularly, to 
increase levels of IL-10 [Fig. 5 A] or to decrease levels of 
TNF [Fig. 5 D]), dermal mast cells must express VDR.
We also analyzed levels of 1,25(OH)2D3 in the skin after 
five UVB exposures, corresponding to the time when mast cell–
  deficient KitW/W-v mice and VDR/ BMCMC→KitW/W-v 
mice exhibited significantly greater increases in ear thickness in 
response to UVB irradiation than did WT or WT BMCMC→
KitW/W-v mice (Fig. 2 A). In all four groups of mice, UVB ir-
radiation resulted in similar, and statistically significant, in-
creases in levels of 1,25(OH)2D3 in the skin (Fig. S4).
In conclusion, we found that mouse mast cells exposed to 
biologically active 1,25(OH)2D3 can produce IL-10 in vitro, 
and that the ability of mast cells to limit the skin inflammation 
and injury, and to enhance cutaneous levels of IL-10, associ-
ated with chronic low-dose UVB irradiation in vivo depends, 
at least in part, on mast cell expression of functional VDRs. 
Our data thus suggest that biologically active 1,25(OH)2D3, 
whose levels are increased after UVB irradiation of the skin, 
can contribute importantly both to the activation of dermal 
mast cells and to the regulation of skin pathology associated 
with extensive UVB exposure. The nature of the mast cell’s 
responses to UVB irradiation may depend on the intensity and 
duration of the UVB exposure, and may vary in different spe-
cies. However, our results in WBB6F1-KitW/W-v mice define 
chronic exposure to UVB irradiation as a setting in which re-
sponsiveness to 1,25(OH)2D3 via mast cell–associated VDR 
can promote antiinflammatory effects of mast cells which in 
turn can substantially limit cutaneous pathology. Our findings 
also raise the possibility that inducing antiinflammatory activi-
ties of mast cells by exposure to 1,25(OH)2D3 might repre-
sent a novel approach for reducing inflammation and tissue 
damage in this and perhaps other settings.
MATERIALS AND METHODS
Mice.  Female  C57BL/6J  (B6)  mice,  VDR-targeted  VDR-deficient 
B6.129S4-Vdrtm1Mbd/J mice backcrossed to C57BL/6 mice for greater than 
eight generations (VDR/ mice), and c-kit mutant genetically mast cell– 
deficient (WB/ReJ-KitW/+ x C57BL/6J-KitWv/+)F1-KitW/Wv (WBB6F1- 
KitW/W-v) (KitW/W-v) mice and the congenic normal WBB6F1-Kit+/+ (Kit+/+) 
mice, were obtained from The Jackson Laboratory and bred in house, either at 
Stanford University or at the Centre for Cancer Biology (Adelaide, Australia). 
All mice were provided ad libitum commercial mouse chow containing Vita-
min D3 (cholecalciferol) at >2,000 IU/kg (Specialty Feeds). Adult KitW/W-v  
versus  KitW/W-v  or  VDR/  BMCMC→KitW/W-v  mice   
(Fig. 2 A). However, levels of skin IL-10 in all groups of 
UVB-treated mice exceeded those in the corresponding con-
trol groups. In addition to mast cells, other potential sources 
of UVB-induced IL-10 in this model include keratinocytes, 
endothelial cells, macrophages and dendritic cells (Nishigori 
et al., 1996; Wolf et al., 2000), as well as CD4+ T cells (par-
ticularly the CD4+CD25+ and FoxP3+ subsets (Beissert et al., 
2006)). 1,25(OH)2D3 can stimulate Th2 development of 
CD4+ T cells, with increased production of IL-4, IL-5 and 
IL-10 (Boonstra et al., 2001); CD4+ T cells thus also repre-
sent one potential source of the higher amounts of IL-4 pro-
tein observed in KitW/W-v mice and VDR/ BMCMC→
KitW/W-v mice compared with the other two groups after 15 
UVB exposures (Fig. 5 B).
IL-6 production by keratinocytes is thought to con-
tribute to UVB-induced cutaneous inflammation (Kirnbauer 
et al., 1991). KitW/W-v mice had the highest levels of IL-6 
after 15 UVB exposures (Fig. 5 C) and exhibited the most 
extensive skin pathology (Fig. 2 A; Fig. 3; and Fig. 4, B 
and D). IL-6 can induce keratinocyte proliferation, sug-
gesting that IL-6 also may contribute to the UVB-induced 
epidermal hyperplasia in KitW/W-v mice (Fig. 3 E and Fig. S3). 
Accordingly, UVB-treated VDR/ BMCMC→KitW/W-v 
mice exhibited levels of skin IL-6 and epidermal thickening 
that were intermediate between those of KitW/W-v mice and 
WT BMCMC→KitW/W-v mice (Fig. 3, D–L; Fig. 5 C; and 
Fig. S3).
Figure 5.  Ear skin cytokine levels 24 h after 4 or 15 UVB expo-
sures. Levels of IL-10 (A), IL-4 (B), IL-6 (C), and TNF (D) in lysates of con-
trol ears not treated with UVB irradiation (– UVB) or ears treated with 4 or 
15 exposures to 2 kJ/m2 UVB irradiation in WBB6F1-Kit+/+ (WT) mice, mast 
cell–deficient WBB6F1-KitW/W-v (KitW/W-v) mice, WT BMCMC→KitW/W-v mice, 
and VDR/ BMCMC→KitW/W-v mice. Data (n = 6–8 per group) are from 
the two experiments performed, each of which gave similar results, in 
which three to four mice/group were tested per experiment. *, P < 0.05;  
**, P < 0.01; ***, P < 0.001; ****, P < 0.0001 for the indicated comparisons.JEM VOL. 207, March 15, 2010  461
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were recorded and epidermal thickness is expressed as mean + SEM per mm 
of ear cartilage.
Measurement of 1,25(OH)2D3 in ear skin lysates. Ear skin samples 
were obtained from mice 24 h after the last of 5 UVB exposures delivered   
2 d apart (each of the 5 exposures was to 2 kJ/m2 UVB) or from control (no 
UVB treatment) mice, and levels of 1,25(OH)2D3 were measured using a 
radioimmunoassay kit according to the manufacturer’s instructions (Immu-
nodiagnostic Systems Ltd). For preparation of mouse ear skin lysates, each 
ear was weighed, split in half along the cartilage and then finely cut up on an 
ice cold surface. Tissue was then snap frozen in liquid nitrogen and placed 
on ice, and then 250 µl of a chloroform-methanol (1:2 vol/vol) extraction 
mixture was added and samples were further disrupted by sonication. Ear 
skin lysates were stored overnight at 80°C, and then centrifuged at 17,000 g 
for 10 min at 4°C. The supernatant was collected and the chloroform-meth-
anol extraction solution evaporated under continuous airflow in a chamber 
until only 50 µl remained. After the addition of 150 µl of 1 x PBS, ear skin 
lysates were then ready for analysis of 1,25(OH)2D3 using the RIA kit. 200 
µl of ear skin lysate from each mouse was analyzed. Each step in the prepara-
tion of the ear skin lysates was performed shielded from light. The data ob-
tained were expressed as picomole/milligram of tissue.
Measurement of cytokines in ear skin lysates. Ear skin lysates were 
prepared as previously described (Grimbaldeston et al., 2007) and IL-10, IL-
4, IL-6, and TNF protein levels in the supernatants were measured by ELISA 
(IL-10 and IL-4 kits; eBioscience; IL-6 and TNF OptEIA kits; BD), accord-
ing to the manufacturer’s instructions, and data obtained from each group 
were expressed as mean + SEM picogram/milligram protein. The lower 
limits of detection were as follows: IL-10 = 30 pg/ml; IL-4 = 4 pg/ml; IL-6 
= 15.6 pg/ml; TNF = 15.6 pg/ml. Total protein levels in the supernatants 
were measured by a Bio-Rad Dc protein assay, according to the manufactur-
er’s instructions (Bio-Rad Laboratories).
BMCMC stimulation and cytokine measurement. At 5 wk of cul-
ture, BMCMCs (2 × 106 cells/ml) were stimulated with 1,25(OH)2D3 
(Sigma-Aldrich) at the various concentrations tested in DMEM (Sigma-
Aldrich) containing WEHI-3–conditioned medium for 24 h and IL-10 
protein levels in the supernatants were measured by ELISA. For stimula-
tion of BMCMCs with IgE, 106 cells/ml were preloaded with IgE anti-
DNP mAb (generated from ascites induced by the hybridoma H1-DNP-26, 
which produces an IgE mAb to DNP [provided by F.-T. Liu, University 
of California-Davis, California, and D.H. Katz, AVANIR Pharmaceuti-
cals, Aliso Viejo, CA]) at a concentration of 2 µg/ml in medium contain-
ing WEHI-3–conditioned medium overnight at 37°C. The mast cells were 
then washed with DMEM supplemented with 0.1% BSA, centrifuged at 
1,000 rpm (250 g) for 5 min at 4°C, plated at 106 cells/ml in 0.1% BSA 
DMEM, and stimulated for 6 h with 20 ng/ml of DNP-HSA–specific an-
tigen (30–40 DNP conjugated to each molecule of HSA [DNP30-40-HSA]; 
Sigma-Aldrich). Levels of IL-6, TNF, and IL-10 in the supernatants were 
measured using ELISA.
-Hexosaminidase degranulation assay. Cells were washed with Ty-
rodes buffer (10 mM Hepes, 129 mM NaCl, 5 mM KCl, 1.4 mM CaCl2,   
1 mM MgCl2, 8.4 mM glucose, and 0.1% BSA), centrifuged, resuspended in 
Tyrodes buffer, plated at a concentration of 2.25 × 106 cells/ml in each well 
of a 96-well v-bottom plate with increasing concentrations of 1,25(OH)2D3 
(0.1–1,000 nM) and incubated at 37°C for 1 or 3 h. As a positive control,   
50 ng/ml PMA/10 µM calcium ionophore A23187 (Sigma-Aldrich) was in-
cluded for one treatment group. Cell supernatants were collected by centrif-
ugation at 1,000 rpm (250 g) for 5 min, and the cell pellet was lysed using 
0.5% Triton X-100 in Tyrodes buffer. Cell supernatants and pellet lysates 
were incubated with 4 mM p-nitrophenyl-N-acetyl--D-glucosaminidine 
(Sigma-Aldrich) in substrate buffer (155 mM Na2HPO4 and 88 mM citric 
acid, pH 4.5) for 1 h at 37°C. -Hexosaminidase activity was detected by 
addition of 0.2 M glycine, pH 10.7, and absorbance at 405 nm was measured 
mice have a profound deficiency of mast cells, including <1.0% the WT level 
of mast cells in the dermis (Galli et al., 2005, 2008). All in vivo experiments 
were performed with age-matched female mice of at least 10 wk of age.   
Experiments were performed in compliance with the ethical guidelines of the 
National Health and Medical Research Council of Australia or with the 
“Guide for the Care and Use of Laboratory Animals” prepared by the Insti-
tute of Laboratory Animal Resources, National Research Council, and pub-
lished by the National Academy Press and with approval from the Institute of 
Medical and Veterinary Science Animal Ethics Committee (Australia) and the 
Stanford Institutional Animal Care and Use Committee.
Preparation and adoptive transfer of BMCMCs into mast cell–
  deficient mice. As previously described (Grimbaldeston et al., 2007), BM-
CMCs were obtained by culturing BM cells from femurs of female mice in 
20% WEHI-3 conditioned medium (containing IL-3) for 4–6 wk, at which 
time >95% of the cells were identified as mast cells by May Grunwald-
  Giemsa staining and by flow cytometric analysis (c-Kit+ FcRI+). For mast 
cell engraftment studies, BMCMCs derived from WT C57BL/6-VDR+/+ 
(WT BMCMCs) or C57BL/6-VDR/ (VDR/ BMCMCs) mice were 
transferred by intradermal injection (i.d.; 2 injections into each ear of 106 
cells in 25 µl DMEM/each injection) into 4–6 wk old KitW/W-v mice. 
Chronic low-dose UVB experiments were initiated 6–8 wk after i.d. transfer 
of BMCMCs.
UV irradiation. For UV irradiation of mice, a bank of 6 Philips FS40T12 
lamps (Ultraviolet Resources International) emitting a broad 270–380–nm 
band of UV, with peak emission at 310 nm comprising 65% of the energy 
emitted, was used to irradiate mice in individual compartments of perspex 
cages. The intensity and spectral output of the UVB lamps were measured 
using a UVX spectrophotometer with a UVX-31 sensor (UV products). A 
new sheet of clear PVC plastic film (0.23 mm thick) was taped to the top of 
each perspex cage before irradiation to screen wavelengths <290 nm. Sun-
lamps were held 15 cm above the cages. 10–14-wk-old mice were conscious 
and had full range of movement during irradiation. For chronic exposures 
the entire mouse (including both ears) was irradiated with a dose of 2 kJ/m2 
UVB (i.e., equivalent to 1 minimal erythema dose as previously determined 
for albino mast cell–deficient WBB6F1-KitW/W-v mice; Grimbaldeston et al., 
2007), every 2 d for a total of 4 or 15 exposures (total cumulative dose = 8 
kJ/m2 or 30 kJ/m2 UVB, respectively). Ear thicknesses were measured using 
a micrometer (Ozaki MFG. CO., LTD.) before each UVB irradiation. Mice 
were killed by CO2 inhalation 24 h after the final UVB exposure and sam-
ples of ear were taken for histology, FACS analysis, and IL-10, IL-4, IL-6, 
and TNF protein measurements.
Histology and quantification of mast cell numbers and epidermal 
thickness. Mice were killed by CO2 inhalation and samples of ear pinna 
were fixed in 10% buffered formalin, embedded in paraffin (with care to en-
sure a cross-sectional orientation), and 4-µm sections were cut. Ear sections 
were stained with hematoxylin and eosin (H&E) stain, or with 0.1% Tolu-
idine blue, pH 1.0, for the detection of mast cells (cytoplasmic granules ap-
pear purple). Ear pinna mast cells were counted in 6–9 consecutive fixed 
fields of 870 µm width using a 10× microscope objective (final magnifica-
tion = 100×), and mast cell numbers were expressed per horizontal ear carti-
lage  field  length  (millimeter),  using  computer-generated  image  analysis 
(NIH Image J software, version 1.29×). The entire length of a strip of skin 
extending from the base to the tip of the ear pinna (5.22–7.83 mm) was 
quantified. After i.d. engraftment of BMCMCs, KitW/W-v mice exhibited 
mast cells from the base to the tip of the ear pinnae, in an anatomical distri-
bution similar to that of the native mast cell populations in the corresponding 
WT mice. For quantification of epidermal thickness, images of 12–30 con-
secutive microscopic fields (435 µm width) of H&E-stained cross sections of 
ear skin from each mouse (n = 6–8/group), performed perpendicular to the 
epidermis, were captured using a 20× microscope objective (200× final 
magnification). For each image, eight randomly selected measurements of 
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Statistical analysis. Analysis of variance (ANOVA) for repeated measures 
was used to assess differences in ear swelling between groups of mice over 
the course of the chronic UVB regimen. For all of our pairwise comparisons 
of the data, before pairwise testing, a one-way ANOVA between groups was 
performed and pairwise analysis using the unpaired, two-tailed, Student’s   
t test was only considered when the ANOVA analysis indicated statistical 
significance. For the occurrence of focal epidermal scabbing and necrosis, we 
employed the 2 test for comparisons between groups. P values >0.05 were 
considered statistically significant. Unless otherwise specified, all data are 
presented as mean + SEM.
Online supplemental material. Fig. S1 shows that 1,25(OH)2D3 can 
increase IL-10 mRNA levels and induce release of IL-10 in WT BMCMCs, 
but not in VDR-deficient BMCMCs, but without inducing BMCMC de-
granulation. Fig. S2 shows that VDR-deficient and WT mast cells exhibit 
similar levels of IgE- and antigen-dependent degranulation and cytokine 
production. Fig. S3 shows the influence of mast cell VDR expression on the 
ability of mast cell populations to limit epidermal thickness associated with 
chronic low-dose UVB irradiation of ear skin. Fig. S4 shows that levels of 
1,25(OH)2D3 in ear skin are increased 24 h after the fifth exposure to UVB 
irradiation. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20091725/DC1.
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